Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 01, 2023

BUY
$197.11 - $250.07 $27,004 - $34,259
137 Added 9.68%
1,552 $331,000
Q3 2022

Nov 02, 2022

BUY
$182.44 - $250.54 $13,135 - $18,038
72 Added 5.36%
1,415 $274,000
Q2 2022

Aug 10, 2022

SELL
$204.13 - $302.4 $5,511 - $8,164
-27 Reduced 1.97%
1,343 $279,000
Q1 2021

May 10, 2021

SELL
$249.67 - $299.48 $13,731 - $16,471
-55 Reduced 3.86%
1,370 $397,000
Q4 2020

Jan 29, 2021

SELL
$222.0 - $252.62 $19,536 - $22,230
-88 Reduced 5.82%
1,425 $356,000
Q3 2020

Nov 10, 2020

SELL
$175.56 - $226.45 $4,389 - $5,661
-25 Reduced 1.63%
1,513 $343,000
Q2 2020

Aug 13, 2020

BUY
$118.84 - $189.72 $182,775 - $291,789
1,538 New
1,538 $268,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.1B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Hunter Associates Investment Management LLC Portfolio

Follow Hunter Associates Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hunter Associates Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hunter Associates Investment Management LLC with notifications on news.